pharmaphorum
MARCH 31, 2021
The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?
pharmaphorum
SEPTEMBER 22, 2021
While there has been incredible progress in the HIV response, nearly 38 million people are living with HIV, with more than a million new cases every year, jeopardising the goal to end AIDS as a public health threat by 2030. HIV places enormous burdens on the communities it affects most, straining health systems and government budgets.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ISPE
MARCH 7, 2023
Transforming Our World: The 2030 Agenda for Sustainable Development.” A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. 1 United Nations.
ISPE
MARCH 6, 2023
[link] A recent study published by My Green Lab 2 presented data from 74 biotechnology and pharmaceutical companies tracking the change in scope 1, 2, and 3 carbon intensity (measured in tons of CO2 emitted vs. the company’s revenue in USD) since 2015. For pharmaceutical companies, purchased goods (e.g.,
ISPE
MARCH 7, 2023
According to the proposal, all packaging shall be designed for recycling by 1 January 2030 and be recycled at scale by 1 January 2035. A pharmaceutical quality system (PQS) is a management system used to direct and control a pharmaceutical company with regard to quality.
Pharmaceutical Technology
JUNE 8, 2023
AstraZeneca has announced its supply chain will be carbon negative by 2030. Of the world’s 20 largest pharmaceutical companies, 17 have launched programmes tailored towards increasing medication access in low- and middle-income countries – up from just eight in 2010. A similar theme is evident in company filings.
Pharmaceutical Technology
DECEMBER 22, 2022
By 2030, JCAs will be carried out on all medicinal products with an EMA-issued MA. Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
Expert insights. Personalized for you.
98 
Let's personalize your content